Background. -Microvascular reflow is crucial for myocyte survival during ischaemia/ reperfusion injury. Aims. -We aimed to assess if salvianolate, a highly purified aqueous extract from Radix salviae miltiorrhizae, could improve impaired microvascular reflow induced by ischaemia/reperfusion injury, using a porcine closed-chest model. Methods. -Left anterior descending coronary artery ligation was created by balloon occlusion for 2 h followed by reperfusion for 14 days. Salvianolate was administrated intravenously for 7 days at low dose (5 mg/kg/day), high dose (10 mg/kg/day) or high dose combined with one 20 mg intracoronary bolus injection just at the beginning of reperfusion. Control-group animals were only given the same volume of saline.
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Background
Reperfusion therapy is the most important therapeutic strategy for improving the prognosis of patients with acute myocardial infarction. However, although Thrombolysis in Myocardial Infarction (TIMI) grade 3 coronary flow is restored, MCE studies showed that about 20-35% of patients had severely reduced tissue-level perfusion [1] . This inadequate tissue perfusion was closely associated with progressive LV remodelling, leading to severe congestive heart failure, and hence, high mortality [2] . Radix salviae miltiorrhizae, known as 'Danshen', is an herb that is widely used in the treatment of cardiovascular diseases in China. The aqueous extract from Danshen has shown beneficial effects in terms of limiting the size of an infarct caused by myocardial ischaemia/reperfusion injury [3, 4] . However, it is not clear whether the aqueous extract from Danshen can improve myocardial microvascular reflow in the setting of ischaemia/reperfusion injury. Salvianolate, as a highly purified aqueous extract from Danshen, contains mainly magnesium lithospermate B (≥ 85%), rosmarinic acid (≥ 10.1%) and lithospermic acid (≥ 1.9%) [5] . In the present study, we aimed to determine whether salvianolate could protect microvascular reflow against ischaemia/reperfusion injury, by using a closedchest porcine model that can minimize the inflammatory responses induced by open-chest surgery, thus mimicking the clinical situation.
Methods
Animal procedures
The protocol was approved by the Animal Care and Use Committee at Shanghai Jiaotong University and conformed to the Chinese Medical Association guidelines for the use of animals in research. On day 1, minipigs (23-30 kg) were sedated with ketamine (15 mg/kg intramuscularly) and anaesthetized with an intravenous infusion of sodium pentobarbital (10 mg/kg initially, then 1 mg/kg as needed), then intubated and mechanically ventilated. Through a right femoral arterial sheath, a 6-F guiding catheter (Amplatz Left 1) was placed into the ostium of the left main coronary artery. The LAD was occluded for 2 h using an intracoronary balloon catheter (15 × 2.5 mm balloon) at the site distal to the second diagonal branch. After reperfusion for 2 h, intravenous anaesthesia was stopped. Sedation with midazolam (1 mg/kg intramuscularly, as needed) was continued for 24 h, during which the right femoral artery and vein remained cannulated for MCE and microsphere injection at 24 h of reperfusion. Blood pressure and heart rate were continuously monitored. During coronary intervention, pigs were heparinized (5000 U bolus followed by 100 U/kg/hour) and then oral aspirin (300 mg) was given daily until euthanization.
On day 8 and day 15 (7 and 14 days after reperfusion, respectively), under sedation with midazolam, the carotid artery was cannulated for microsphere injection, while the carotid vein was used for MCE contrast injection.
After 14 days of reperfusion, the LAD was reoccluded and 2% Evans Blue dye was injected into the LAD via a carotid venous sheath, to identify the risk area. The animals were then euthanized and the heart was rapidly removed and cut into five short-axis slices, perpendicular to the ventricular septum from the base to the apex of the heart (6-8 mm thick; labelled as S1 to S5, respectively). All five slices were weighed and recorded.
Study groups
After LAD occlusion, pigs were randomized into the following groups: Group I (saline control), normal saline without salvianolate; Group II, 5 mg/kg salvianolate diluted with 100 mL saline and given intravenously at a rate of 100 mL/hour, starting 30 min before reperfusion; the same dose was repeated once a day for 7 days; Group III, as for Group II but using 10 mg/kg salvianolate; Group IV, in addition to the same intravenous dose as Group III, 20 mg salvianolate in 2 mL saline given through an over-the-wire balloon catheter just after reperfusion.
Drug under investigation
Salvianolate is derived from the dried root of cultivated Radix salviae miltiorrhizae and manufactured by Greenvalley Pharmacia (Shanghai, China), using the technique described previously [6] . The manufacture and clinical application of salvianolate was granted by the State Food and Drug Administration of China in 2005. The major active component, magnesium lithospermate B (content > 85%), is detected for quality control during production. The other components of salvianolate consist of different phenol salts, including magnesium lithospermate, dipotassium lithospermate, sodium rosmarinate, potassium Danshensu, dipotassium isolithospermate B and magnesium salvianolate G.
Salvianolate is recommended for use at a dose of 200 mg/day (3.3 mg/kg/day for an adult weighing 60 kg) in the treatment of chronic stable ischaemic heart disease [7] . The equivalent dose for a minipig is approximately 5 mg/kg according to the exchange coefficient determined by surface area. In the present study, we selected an equivalent standard dosage (5 mg/kg/day) and a higher dosage (10 mg/kg/day) for investigation.
Myocardial contrast echocardiography examination
In order to detect MBF, real-time MCE was performed with a Sequoia 512 machine (Acuson, Mountain View, CA, USA) at different time points, including baseline, 2 h after LAD occlusion, and 2 h, 24 h, 7 days and 14 days after reperfusion, using the methodology described previously [8] . Briefly, after gain settings were optimized, real-time perfusion images were acquired from the short-axis papillary muscle view (mechanical index of 0.17), while SonoVue (Bracco Diagnostics, Inc., Geneva, Switzerland) was infused at a rate of 1 mL/minute via a femoral or carotid venous sheath. After high-energy flash frames (mechanical index of 1.9) lasting for 10 cardiac cycles were manually triggered to destroy the microbubbles within the myocardium, continuous refilling sequences of 15 cardiac cycles were obtained and recorded on magnetic optical disks.
The risk area was identified as the region of opacification defect during LAD occlusion. The perfusion defect area was manually traced for the final three end-diastolic images of the 15-cycle refilling sequence. The risk area was expressed as percentage of left ventricle and the reperfusion defect area was expressed as percentage of risk area.
For quantitative analysis, the sample volume was placed in the risk area (region of interest) avoiding both the epicardium and the endocardium. Using Cardio U/S Quantification software (Version 1.4; Siemens Healthcare, Erlangen, Germany), quantitative perfusion data were obtained by fitting intensity data to an exponential function: y = A (1−e −␤t ) + C, where y is the signal intensity at any given time; A is the plateau signal intensity that reflects the microvascular cross-sectional area; ␤ is the rate of signal intensity rise that reflects myocardial microbubble velocity; t is the time after the high-energy flash frames; and C is the intercept at the origin reflecting the background intensity level. The product (A × ␤) correlates with MBF. Because the value of A can be affected by various factors, including gain and attenuation, it was normalized to the A value derived from the adjacent LV cavity [9] .
Measurement of myocardial blood flow
MBF was also quantified using 15 m coloured microspheres (Dye-Trak, Triton Technology, Inc., South Easton, MA, USA) as described previously [10] . Via the femoral or carotid artery sheath, a pigtail catheter was introduced into LV cavity. After being thoroughly vibrated for optimal mixing, an adequate amount of microspheres [11] was injected into the LV cavity for 10 s. A 10 mL bolus of warm saline was immediately injected to wash out the catheter. A reference arterial blood sample was continuously aspirated from 10 s before microsphere injection until 60 s after the injection, at a rate of 5.8 mL/minute. The microsphere injection was repeated at different time points with different colours. After the animal was euthanized after 14 days reperfusion, the anterior wall on the S3 heart tissue slice was used for quantification analysis. Microspheres were recovered by a sedimentation process. The microsphere dye was then extracted and MBF (mL/minute/g) was calculated.
Evaluation of the effects of myocardial contrast echocardiography and myocardial blood flow examination on haemodynamics
To ensure that MCE and microsphere examination had no side effects on microcirculation, a pilot study was done on four normal minipigs without any intervention. MCE and microsphere injection was done at baseline, and 2 and 4 h after anaesthesia on days 1, 2, 8 and 15; time course changes in microcirculation and cardiac function were quantified.
Myocardial function measurement by transthoracic echocardiography
While the animal was sedated for MCE examination at each time point, as described above, transthoracic echocardiography was performed, using a Sequoia 512 machine with a 1.75-3.5 MHz transducer. LV dimensions and wall thickness were measured from the parasternal short-axis view at papillary muscle level. Wall thickening and fractional area change were calculated and expressed as percentages [12] . LV volume was measured from the apical four-chamber view and LV ejection fraction was determined by Simpson's method.
Histological assessment
For infarct size quantification, only three slices (S1, S3 and S5) were incubated in 1% triphenyltetrazolium chloride at 37 • C for 15 minutes. The infarct size (stained in the pale area) and risk area (delineated with Evans Blue dye) were measured by planimetry (ImageJ 1.36, National Institutes of Health, Bethesda, MD, USA) at both the apical and basal sides of the three slices. The infarct areas or risk areas for slices S1, S3 and S5 were the average of the apical and basal values of each slice; the values for slice S2 were the average of the basal side of S3 and the apical side of S1; and the values for slice S4 were the average of the basal side of S5 and the apical side of S3. Summation of the infarct weights of all slices was obtained and the infarct size was expressed as a percentage of the total weight of the left ventricle and as the total weight of the risk area.
The heart tissue slices S2 and S4 were used for immunohistochemistry, protein expression and oxidative stress measurement. For the histochemistry examination, the tissue was fixed with 4% paraformaldehyde, paraffin embedded and then sliced at a thickness of 5 m. Endothelial cells were stained using rabbit antihuman vWF antibody (Dako Denmark A/S, Glostrup, Denmark). Capillary density was calculated in 20 random high-power fields (400 ×) and expressed as the number per mm 2 .
Terminal deoxynucleotide transferase-mediated dUTP nick end labelling and endothelial cell staining
TUNEL staining was performed using a commercially available kit (Nanjing KeyGen Biotech. Co. Ltd., Nanjing, China). The cell nuclei were labelled with 4'6-diamidino-2-phenylindole (DAPI), while endothelial cells were labelled with antibody against vWF. For each animal, at least 10 randomly selected high-magnification fields (400 ×) from five different sections were analysed. The apoptotic index was calculated as the ratio of TUNEL-positive cells to total cells, while the endothelial cell apoptotic index was calculated as the ratio of TUNEL-positive endothelial cells to total endothelial cells.
Assessment of tissue concentrations of superoxide dismutase, glutathione, malondialdehyde and nitric oxide
The tissue levels of superoxide dismutase enzyme activity and tissue concentrations of glutathione, malondialdehyde and nitric oxide were all determined spectrophotometrically using appropriate kits purchased from the Jiancheng Bioengineering Institute (Nanjing, China), according to the manufacturer's instructions. The protein concentration of heart tissue homogenates was determined with the bicinchoninic acid (BCA) assay (BioTime Inc., Haimen, China).
Thioredoxin activity assessment
Using the same method as described previously [13, 14] , the activity of thioredoxin was determined for heart tissue from the infarct area using an insulin reduction assay, where insulin is reduced by thioredoxin with NADPH in the presence of excess thioredoxin reductase. Briefly, after tissue homogenization, 40 g protein in a volume of 68 L plus 2 L DTT activation buffer (composed of 50 mM HEPES [pH 7.6], 1 mM EDTA, 1 mg/mL BSA and 2 mM DTT) were incubated at 37 • C for 15 min to reduce thioredoxin, then 40 L of the reaction mixture (containing 250 mM HEPES [pH 7.6], 10 mM EDTA, 2.4 mM NADPH and 6.4 mg/mL insulin) were added. The reaction began with the addition of 10 L of rat thioredoxin reductase (90.899 A412 U/mL; Sigma-Aldrich Inc., St. Louis, MO, USA) followed by incubation for 20 min at 37 • C. The reaction was stopped by the addition of 0.5 mL of 6 M guanidine-HCl and 1 mM DTNB (3-carboxy-4-nitrophenyl disulfide). For each sample, the absorbance at 412 nm was adjusted by subtracting the absorbance reading without thioredoxin reductase. One unit of activity was calculated using the following formula: A 412 × 0.62/(13.6 × 2). 
Western blotting
Tissue homogenates was separated by 12% SDS-PAGE and then transferred to a polyvinylidene-difluoride membrane (Millipore, Billerica, MA, USA). After blocking with 5% skimmed milk, membranes were incubated with a first antibody targeting Bcl-2 and Bax (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), followed by the corresponding HRP-conjugated second antibody. An enhanced chemiluminescence reagent western blotting detection kit (Pierce Biotechnology, Inc., Rockford, IL, USA) was finally used to measure immunoreaction with a light-sensitive film (Kodak, Rochester, NY, USA). The band for each protein was then quantified by densitometry with ImageJ software.
Statistical analysis
All data are presented as means ± standard deviations. Intergroup differences were determined by one-way analysis of variance and when statistical significance was found in a group, pairwise comparisons were made using the Student-Newman-Keuls post-hoc test. A value of P < 0.05 was considered statistically significant.
Results
Time course changes in haemodynamics: pilot study
In the pilot study, during repeated MCE examination and microsphere injection, no significant changes were detected in heart rate, blood pressure and LV systolic function, or in A, ␤, (A × ␤) and MBF (Table 1) .
Haemodynamics, cardiac function and infarct size assessment
Five pigs died of ventricular fibrillation after occlusion. During the initial 12 h of reperfusion, one pig died in Group I, one died in Group III and two died in Group IV. The data from these animals were excluded. The remaining 33 pigs (9 from Group I; 8 from Group II; 8 from Group III; 8 from Group IV) were evaluated. Heart rate was significantly increased (P < 0.001) and blood pressure was significantly lower (P < 0.001) after LAD occlusion (Table 2 ). However, there was no significant difference between the four groups in terms of heart rate and blood pressure. LAD occlusion caused a significant decrease in regional anterior wall thickening, as well as LV ejection fraction and fractional area change (P < 0.001, respectively). At 14 days of reperfusion, these variables were all significantly improved with high-dose treatment (Groups III and IV) compared with Group I (P < 0.001, respectively; Table 3 ).
High-dose salvianolate resulted in a significant decrease in infarct size in Group III (p = 0.025) and Group IV (p = 0.032) compared with Group I, although there was no significant difference between Groups III and IV (Table 4 ).
Microvascular reflow by real-time myocardial contrast echocardiography
The risk area measured by MCE at 2 h of LAD occlusion was similar in all groups (Table 4 ). High-dose salvianolate administration (Groups III and IV) resulted in a significant decrease in the defect area after reperfusion ( Fig. 1 ; P < 0.001, respectively; Table 4 ). Quantitative MCE showed a reduction in A, ␤ and (A × ␤) in LAD territories after occlusion (P < 0.001). The variables recovered at the onset of reperfusion but deteriorated gradually over the following 14 days. Compared with Group I, after reperfusion for 14 days, the variables were significantly improved in Groups III and IV (P <0.001; Table 5 ). No significant difference was detected between Groups III and IV. 
Myocardial blood flow examination
MBF measured by microspheres revealed the severe decrease in blood flow in the LAD regions after occlusion (P < 0.001). At the onset of reperfusion, MBF recovered significantly but decreased gradually thereafter. Compared with Group I, MBF was significantly higher in the highdose groups (Groups III and IV; P < 0.001; Table 5 ). No significant difference was found between Groups III and IV.
The variable (A × ␤) derived by MCE correlated with MBF assessed by microspheres (r = 0.785; P < 0.001). 
Immunohistochemical staining for capillary density measurement
The density of capillaries that stained positive for vWF in the ischaemic area was significantly higher in Group II (895 ± 311/mm 2 ), Group III (855 ± 92/mm 2 ) and Group IV (588 ± 99/mm 2 ) compared with Group I (350 ± 146/mm 2 ; P < 0.001, respectively; Fig. 2 ) with no significant differences between the salvianolate groups.
Effect of salvianolate on myocardial oxidative stress
High-dose salvianolate (Groups III and IV) resulted in a higher level of superoxide dismutase activity and a higher concentration of glutathione in heart tissue, whereas the concentration of malondialdehyde was significantly decreased, compared with Group I (P < 0.001, respectively; Table 6 ). Interestingly, the concentration of nitric oxide in the infarcted area was not significantly different between the four groups.
Effect of salvianolate on myocardial thioredoxin activity
Myocardial thioredoxin activity was significantly increased in Groups III and IV compared with Group I (P < 0.001, respectively).
Effect of salvianolate on apoptosis
TUNEL staining showed that the apoptosis ratios for total cells and endothelial cells in the infarct area were significantly decreased in Groups III and IV, compared with controls (P < 0.001, respectively, Fig. 3) . Consistently, the ratio of Bcl-2/Bax was significantly higher in Groups III and IV than in Group I (P < 0.001, respectively; Fig. 4 ).
Discussion
The present study for the first time investigated the protective effect of salvianolate, a highly purified aqueous extract from Danshen, on microcirculation after myocardial ischaemia/reperfusion injury. Impaired microvascular circulation is a pathological process that begins during ischaemia and progresses upon reperfusion, the mechanism of which is still not fully understood [15] . We deliberately delivered the drug during the ischaemic period, allowing a stable blood concentration be established before reperfusion started, although the protective effects might also involve attenuation of ischaemic injury rather than pure reperfusion injury. Nevertheless, in the present study, we clearly showed that salvianolate given intravenously at a dose of 10 mg/kg/day for 7 days, with the first dose delivered before reperfusion, significantly limited reperfusion defect size expansion on MCE, and enhanced MBF recovery, as evidenced by an elevated (A × ␤) value on MCE and MBF measured by coloured microspheres. The protection provided by salvianolate, evidenced by a decrease in infarct size and enhanced LV systolic function, was also present at a high dose of salvianolate. Previous pharmacokinetic studies have verified that blood concentration linearly correlates with the dose of magnesium lithospermate B, the major component of salvianolate, when given intravenously [16] . We also observed a trend of dose-dependent effects with most of the variables we tested, which was not statistically significant. However, our results suggest that a high dose may be necessary to achieve the maximal minimizing effect on ischaemia/reperfusion injury; this has been suggested in previous studies [4, 17] . In addition, we also observed that one extra intracoronary injection of 20 mg salvianolate, delivered directly to the ischaemic myocardium, failed to provide further protection, indicating that maximal effects might be reached with the high dose of intravenous salvianolate alone.
Microsphere injection has been shown to quantify microvascular blood flow precisely without affecting systemic haemodynamic variables [10, 18] ; this was confirmed in our pilot study, with dose carefully adjusted by weight [11] . Thus, our data suggest that repeated injections of microspheres do not significantly affect microcirculation.
In our study, triphenyltetrazolium chloride staining was performed 14 days after reperfusion. However, when we injected Evans Blue dye to delineate the risk area, we noticed that the dye can perfuse into the risk zone, making this methodology impractical for quantification of infarct size at the late phase of reperfusion. This phenomenon could be due to neovascularization in the risk zone after 14 days of reperfusion [19] . Fortunately, however, the risk zone can still be clearly defined by MCE examination. Thus, the infarct size was expressed as a percentage of the total left ventricle rather than the risk area.
Overproduction of oxygen-derived free radicals plays a key role in ischaemia/reperfusion injury [20] , leading to increased apoptosis activation during reperfusion [21, 22] . Our data show that a high dose of salvianolate resulted in a decrease in malondialdehyde concentration and an increase in superoxide dismutase activity, glutathione concentration and thioredoxin activity in the ischaemic myocardium. Thioredoxin has been recently proven to be crucial for maintaining activity of antioxidative enzymes [23] and plays a key role in the antiapoptotic signalling pathway [24] . In our study, this protection was evidenced by an increase in the Bcl-2/Bax protein expression ratio and suppressed apoptotic cells, especially apoptotic endothelial cells. Our observations were consistent with previous reports [25] [26] [27] . Thus, we have confirmed that salvianolate improves microvascular reflow via suppression of oxidative stress and apoptosis.
The recommended dose of 200 mg/day has been proven to be safe by several experimental and clinical studies [7] . In our present study, no significant changes in arterial blood pressure and heart rate were observed during salvianolate infusion. Thus, an intravenous dose of 10 mg/kg/day (equivalent to a dose of 400 mg/day in humans) is safe for pigs. A large-scale clinical study is certainly warranted to further evaluate its beneficial effects and drug-related side effects.
In conclusion, using a closed-chest porcine model of myocardial ischaemia/reperfusion injury, we demonstrated that 7-day treatment with high-dose salvianolate (10 mg/kg per day, intravenously) significantly improved microvascular reflow, resulting in smaller infarct size and enhanced LV systolic function. The protective effect of salvianolate was closely associated with its strong antioxidative and antiapoptotic effects.
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